Edenlux
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $14M
Investors
- 6
About Edenlux
Founded in 2016, Edenlux operates from Busan, South Korea, focusing on optical health products.Edenlux specializes in eye health products, focusing on the OTUS Plus, an eye exercise device designed to alleviate visual fatigue and promote ocular wellness. This product is supported by over a decade of research, targeting common vision impairment and eye strain issues. The OTUS Plus allows users to integrate eye relaxation exercises into their daily routines, especially beneficial for individuals with prolonged screen exposure, such as office workers and students.Edenlux generates revenue through direct-to-consumer sales of the OTUS Plus. Customers can purchase the device directly from their online platform, and the transaction model is based on one-time purchases. The company enhances customer engagement through support on platforms like KakaoTalk, contributing to a sustainable revenue stream and brand loyalty among users. The company is designing additional eye health solutions, with specific release dates yet to be announced. They aim to broaden their reach beyond South Korea to include markets across Asia and North America within the next few years.
Who invested in Edenlux
6 investors across 4 rounds
See all investors in Edenlux
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Edenlux
Who invested in Edenlux?
Edenlux has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Edenlux raised?
Edenlux has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Edenlux last raise money?
Edenlux's most recent round on record is a Series B, in Mar 2022.
What does Edenlux do?
Founded in 2016, Edenlux operates from Busan, South Korea, focusing on optical health products.
Where is Edenlux headquartered?
Edenlux is headquartered in Busan, South Korea.
Which VCs invest in companies like Edenlux?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare specialists companies at Edenlux's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like Edenlux? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.